Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.938 USD | +1.97% | -3.12% | -33.21% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Bearish |
Resistance | 1.190 | 1.560 | 1.801 |
Spread/Res. | -21.43% | -40.06% | -48.07% |
Spread/Supp. | +66.99% | +66.99% | +66.99% |
Support | 0.5599 | 0.5599 | 0.5599 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MCRB Stock
- Charts Seres Therapeutics, Inc.